Needle | $2,200,000 | (Mar 4, 2025)
Sparta | $42,000,000 | (Mar 4, 2025)
PassEntry | $6,613,932 | (Mar 4, 2025)
Certified by Founder
Lodge
Avenue Therapeutics
start up
United States
- New York, NY
- 13/12/2021
- Unknown
- $2,000,000
Avenue Therapeutics, Inc. (NASDAQ: ATXI), a Fortress Biotech (NASDAQ: FBIO) Company, is a specialty pharmaceutical company.
Please be aware of Recruiting Fraud: https://www.avenuetx.com/beware-of-recruiting-fraud/
- Industry Biotechnology Research
- Website https://www.avenuetx.com/
- LinkedIn https://www.linkedin.com/company/avenue-therapeutics/
Related People
Lucy LuFounder
United States -
New York City Metropolitan Area
I am an executive of a development-stage biotech company. Prior to working in the biotech industry, I was a senior equity analyst covering small- to mid-cap biotechnology companies. My expertise includes strategic planning, clinical development, regulatory strategy, business development, biotech equity valuation, investor relations and capital markets.
QRaGo | $2,830,856 | (Mar 4, 2025)
Atmosic Technologies | $40,000,000 | (Mar 4, 2025)
Koala | $15,000,000 | (Mar 4, 2025)
SkyMirr Inc | $7,300,000 | (Mar 4, 2025)
FluxGen | $3,205,440 | (Mar 4, 2025)
Actual Veggies | $7,000,000 | (Mar 4, 2025)
TakeMe2Space | $629,500 | (Mar 4, 2025)
Lizzy Care | $2,600,000 | (Mar 4, 2025)
Jurimesh | $2,000,000 | (Feb 28, 2025)